(Q39151249)

9 September 2017

title

Design, characterization and in vitro evaluation of SMEDDS containing an anticancer peptide, linear LyP-1. (English)

1 reference

9 September 2017

R Neslihan Gürsoy

1

1 reference

9 September 2017

Özge Çevik

series ordinal

2

1 reference

9 September 2017

publication date

16 May 2013

1 reference

Pharmaceutical Development and Technology

9 September 2017

published in

1 reference

9 September 2017

volume

19

1 reference

9 September 2017

issue

4

1 reference

9 September 2017

page(s)

486-490

1 reference

Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Nanocrystal targeting in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Tumor targeting of baculovirus displaying a lymphatic homing peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Crystal structure of human p32, a doughnut-shaped acidic mitochondrial matrix protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

p32 protein, a splicing factor 2-associated protein, is localized in mitochondrial matrix and is functionally important in maintaining oxidative phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Differential expression of Hyaluronic Acid Binding Protein 1 (HABP1)/P32/C1QBP during progression of epidermal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Lipid-based formulations for intestinal lymphatic delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Liposomes to target the lymphatics by subcutaneous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Enhanced oral bioavailability of etodolac by self-emulsifying systems: in-vitro and in-vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Excipient effects on in vitro cytotoxicity of a novel paclitaxel self‐emulsifying drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Evaluation of cytotoxicity of oils used in coenzyme Q10 Self-emulsifying Drug Delivery Systems (SEDDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Lipids promote survival, proliferation, and maintenance of differentiation of rat liver sinusoidal endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

The multicompartmental p32/gClqR as a new target for antibody-based tumor targeting strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Potential therapeutic strategies for lymphatic metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Lymphatic targeting with nanoparticulate system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.795170

10.3109/10837450.2013.795170

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference